Vargatef® (nintedanib) | Boehringer Connect

Skip to main content

This website is for UK healthcare professionals.

Contact

Search form

Search

Home
Cardiovascular
Diabetes
- Trajenta^®(linagliptin)
- Jardiance^®(empagliflozin)
IPF
- OFEV^®(nintedanib esilate)
Oncology
- GIOTRIF^®(afatinib dimaleate)
- VARGATEF^®(nintedanib esilate)
Respiratory
- COPD
  - Spiolto^® Respimat^®(tiotropium & olodaterol)
  - Spiriva^® Respimat^®(tiotropium)
- Asthma
  - Spiriva^® Respimat^®(tiotropium)
Thrombosis
- Actilyse^®(alteplase)
- Actilyse^® Cathflo^® 2mg(alteplase)
Healthcare Commissioners
Contact

Home
Oncology
Vargatef^® (nintedanib)

Responsive Banner

Vargatef^{^®} (nintedanib) Prescribing Information

Video

A short video of the dosing regimen for VARGATEF^® (nintedanib)
Article

Efficacy and safety of VARGATEF^® (nintedanib) plus docetaxel

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

Information intended for:

UK HEALTHCARE PROFESSIONALS

Click here if you are a UK Healthcare professional and would like more information on Boehringer Ingelheim Medicines

UK HEALTHCARE PROFESSIONAL WEBSITE

Information intended for:

MEMBERS OF THE PUBLIC, CARERS & PATIENTS

Click here if you are a member of the public, carer or patient and would like more information on Boehringer Ingelheim Medicines

MORE INFORMATION ON BOEHRINGER INGELHEIM MEDICINES

Reporting adverse events

Adverse events should be reported. Reporting form and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in package leaflet.

You can also report side effects directly to the Yellow Card scheme of www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of the medicine.

For more information, or to access the current prescriber guides and summary of product characteristics, please visit www.medicines.org.uk/emc

NP-UK-100172 V1 – March 2019

Accessibility Statement
Privacy and Cookie Policy
Terms of Use
Product Information

© 1999-2018 Boehringer Ingelheim GmbH All rights reserved.

PC-GB-101709 Date of preparation May 2020